EBOS.F Stock Overview
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
EBOS Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$22.44 |
| 52 Week High | NZ$22.44 |
| 52 Week Low | NZ$22.44 |
| Beta | 0.26 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 6.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| EBOS.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | 2.9% |
| 1Y | n/a | 1.7% | 22.2% |
Return vs Industry: Insufficient data to determine how EBOS.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how EBOS.F performed against the US Market.
Price Volatility
| EBOS.F volatility | |
|---|---|
| EBOS.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EBOS.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EBOS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 5,000 | John Cullity | www.ebosgroup.com |
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
EBOS Group Limited Fundamentals Summary
| EBOS.F fundamental statistics | |
|---|---|
| Market cap | US$3.94b |
| Earnings (TTM) | US$168.16m |
| Revenue (TTM) | US$8.28b |
23.4x
P/E Ratio0.5x
P/S RatioIs EBOS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBOS.F income statement (TTM) | |
|---|---|
| Revenue | AU$12.67b |
| Cost of Revenue | AU$11.09b |
| Gross Profit | AU$1.58b |
| Other Expenses | AU$1.33b |
| Earnings | AU$257.35m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 21, 2024
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 12.49% |
| Net Profit Margin | 2.03% |
| Debt/Equity Ratio | 62.3% |
How did EBOS.F perform over the long term?
See historical performance and comparison